Takeaway
Cerebrospinal fluid (CSF) neurofilament light protein (NfL) could be a valuable biomarker of early neurodegeneration but is not specific to the pathobiology of Alzheimer’s disease (AD).
Why this matters
Previous work has not investigated CSF markers in the community or investigated them in relation to mild cognitive impairment.